Clinical Trial Update: Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral Palsy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of botulinum toxin on selective motor control and pain in individuals with diplegic cerebral palsy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Cerebral Palsy Spastic Diplegia

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Gaziosmanpasa Research and Education Hospital | Conditions: Cerebral Palsy Spastic Diplegia | Phase 4 | Status: COMPLETED